Minako Maruyama

Validation of Gene Therapy for Mutant Mitochondria by Delivering Mitochondrial RNA Using a MITO-Porter

Eriko Kawamura, Minako Maruyama, Jiro Abe et al. · Molecular Therapy — Nucleic Acids · 2020 · 77 citations · Full text

Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors

Kazuki Shimizu, Minako Maruyama, Yuka Yasui et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 61 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Hypoxia-inducible Factor +10

The use of a MITO-Porter to deliver exogenous therapeutic RNA to a mitochondrial disease’s cell with a A1555G mutation in the mitochondrial 12S rRNA gene results in an increase in mitochondrial respiratory activity

Yuma Yamada, Minako Maruyama, Tomoko Kita et al. · Mitochondrion · 2020 · 33 citations

Mitochondrial Respiratory Activity, Mitochondrial Biogenesis, Mitochondrial Function +9

Development of hypoxia-inducible factor (HIF)-1α inhibitors: Effect of ortho-carborane substituents on HIF transcriptional activity under hypoxia

Hiroyuki Nakamura, Yuka Yasui, Minako Maruyama et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 26 citations

Transcriptional Regulation, Hypoxia-inducible Factor, Hif Transcriptional Activity +11

Development of a nanoparticle that releases nucleic acids in response to a mitochondrial environment

Yuma Yamada, Yutaka Fukuda, Daisuke Sasaki et al. · Mitochondrion · 2020 · 20 citations

Nanoparticles, Dna Nanotechnology, Nucleic Acid Chemistry +10